147 related articles for article (PubMed ID: 25271879)
1. Central diabetes insipidus: alert for dehydration in very low birth weight infants during the neonatal period. A case report.
Ferlin ML; Sales DS; Celini FP; Martinelli Junior CE
Sao Paulo Med J; 2015 Feb; 133(1):60-3. PubMed ID: 25271879
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic central diabetes insipidus in an extreme premature infant: A case report.
Biset A; Claris O
Arch Pediatr; 2018 Nov; 25(8):480-484. PubMed ID: 30361085
[TBL] [Abstract][Full Text] [Related]
3. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
4. Central Diabetes Insipidus in a Preterm Neonate Unresponsive to Intranasal Desmopressin.
Hussain A; Baier RJ; Mehrem AA; Soylu H; Fraser D; Elsayed Y
Neonatal Netw; 2020 Nov; 39(6):339-346. PubMed ID: 33318230
[TBL] [Abstract][Full Text] [Related]
5. Profound hypernatremia due to central diabetes insipidus.
Vaqar A; Rafiq A; Javaid KH; Parveen R; Sadaf R
J Coll Physicians Surg Pak; 2012 Jun; 22(6):409-11. PubMed ID: 22630107
[TBL] [Abstract][Full Text] [Related]
6. Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.
Djermane A; Elmaleh M; Simon D; Poidvin A; Carel JC; Léger J
J Clin Endocrinol Metab; 2016 Feb; 101(2):635-43. PubMed ID: 26588450
[TBL] [Abstract][Full Text] [Related]
7. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
8. Central diabetes insipidus related to anti-programmed cell-death 1 protein active immunotherapy.
Deligiorgi MV; Siasos G; Vergadis C; Trafalis DT
Int Immunopharmacol; 2020 Jun; 83():106427. PubMed ID: 32244049
[TBL] [Abstract][Full Text] [Related]
9. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
10. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
11. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic central diabetes insipidus presenting in a very low birth weight infant successfully managed with lyophilized sublingual desmopressin.
Hanta D; Törer B; Temiz F; Kılıçdağ H; Gökçe M; Erdoğan Ö
Turk J Pediatr; 2015; 57(1):90-3. PubMed ID: 26613228
[TBL] [Abstract][Full Text] [Related]
13. Congenital toxoplasmosis complicated with central diabetes insipidus in the first week of life.
Nitta A; Suzumura H; Kano K; Arisaka O
J Pediatr; 2006 Feb; 148(2):283. PubMed ID: 16492446
[No Abstract] [Full Text] [Related]
14. Severe hyperosmolarity and hypernatremia in an adipsic young woman.
Latcha S; Lubetzky M; Weinstein AM
Clin Nephrol; 2011 Nov; 76(5):407-11. PubMed ID: 22000562
[TBL] [Abstract][Full Text] [Related]
15. A patient with essential hypernatremia had good response to desmopressin acetate therapy.
Guo Q; Lu J; Mu Y; Dou J; Pan C
Neuro Endocrinol Lett; 2010; 31(5):588-93. PubMed ID: 21173753
[TBL] [Abstract][Full Text] [Related]
16. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
17. Persistent central diabetes insipidus presenting in a very low birth weight infant successfully managed with intranasal dDAVP.
Stapleton G; DiGeronimo RJ
J Perinatol; 2000 Mar; 20(2):132-4. PubMed ID: 10785891
[TBL] [Abstract][Full Text] [Related]
18. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
19. Persistent hypernatremia secondary to adipsic central diabetes insipidus in a patient with herpes-induced meningoencephalitis and COVID-19 infection: a case report.
Cherchir F; Oueslati I; Salhi S; Ben Hamida A; Yazidi M; Chihaoui M
J Int Med Res; 2024 Mar; 52(3):3000605241235747. PubMed ID: 38502003
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
Decaux G; Prospert F; Namias B; Soupart A
Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]